Get Live Data

The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

  2. Share Prices
  3. Glaxosmithkline Share Price
  4. Glaxosmithkline Share News
  5. UK Dividends Calendar - Week Ahead

Pin to quick picksGlaxosmithkline Share News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,770.00
Bid: 1,769.50
Ask: 1,770.50
Change: 9.00 (0.51%)
Spread: 1.00 (0.057%)
Open: 1,770.00
High: 1,775.50
Low: 1,766.00
Prev. Close: 1,761.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Dividends Calendar - Week Ahead

Tue, 13th May 2014 15:30

UK Dividends Calendar 
Wednesday, May 14 
J SainsburyEx-dividend date 2013
Sage GroupEx-dividend date 2014
SercoPayment date 2013 dividend
Air PartnerEx-dividend date 2013
Morgan Advanced MaterialsEx-dividend date 2013
BarclaysEx-dividend date 2014
St IvesPayment date 2014 dividend
Aberdeen Asset ManagementEx-dividend date 2014
AlentEx-dividend date 2013
European Assets TrustEx-dividend date 2014
Fidessa GroupEx-dividend date 2013
GlaxoSmithKlineEx-dividend date 2014
Kingfisher GroupEx-dividend date 2013
Standard CharteredEx-dividend date 2013
CarillionEx-dividend date 2013
InmarsatEx-dividend date 2013
Management Consulting GroupEx-dividend date 2013
Medicx FundEx-dividend date 2014
Numis CorporationEx-dividend date 2014
Polar Capital Global Healthcare Growth & IncEx-dividend date 2014
Royal Dutch ShellEx-dividend date 2014
Glencore XstrataEx-dividend date 2013
Picton Property IncomeEx-dividend date 2014
BlackRock Smaller Companies TrustEx-dividend date 2013
British & American Investment TrustEx-dividend date 2013
JZ Capital PartnersEx-dividend date 2014
Anglo-Eastern PlantationsEx-dividend date 2013
British Polythene IndustriesEx-dividend date 2013
RegenersisEx-dividend date 2013
Fidessa GroupSpecial dividend payment date
MallettSpecial dividend payment date
Thursday, May 15 
LadbrokesPayment date 2013 dividend
MelrosePayment date 2013 dividend
BlackRock World Mining TrustPayment date 2013 dividend
Melrose IndustriesPayment date 2013 dividend
Noble CorporationPayment date 2013 dividend
Tullett PrebonPayment date 2013 dividend
Photo-Me InternationalSpecial dividend payment date
Friday, May 16 
J SainsburyRecord date 2013 dividend
SageRecord date 2014 dividend
Kier GroupPayment date 2014 dividend
Man GroupPayment date 2014 dividend
HG Capital TrustPayment date 2013 dividend
AvivaPayment date 2013 dividend
DevroPayment date 2013 dividend
Novae GroupPayment date 2013 dividend
Murray International TrustPayment date 2013 dividend
Aberdeen Asian Income FundPayment date 2013 dividend
Arbuthnot Banking GroupPayment date 2013 dividend
ARM HoldingsPayment date 2013 dividend
Carrs Milling IndustriesPayment date 2014 dividend
T ClarkePayment date 2013 dividend
Drax GroupPayment date 2013 dividend
Johnson Service GroupPayment date 2013 dividend
Millennium & Copthorne HotelsPayment date 2013 dividend
Jupiter Dividend & Growth TrustPayment date 2014 dividend
St James's PlacePayment date 2013 dividend
Millennium & Copthorne HotelsSpecial dividend payment date
Novae GroupSpecial dividend payment date
Monday, May 19 
John Laing Infrastructure FundPayment date 2013 dividend
Rathbone BrothersPayment date 2013 dividend
IMIPayment date 2013 dividend
Unite GroupPayment date 2013 dividend
RotorkPayment date 2013 dividend
Tuesday, May 20 
Direct Line GroupPayment date 2013 dividend
CommunisisPayment date 2013 dividend
John Wood GroupPayment date 2013 dividend
F&C Asset ManagementPayment date 2013 dividend
Intu PropertiesPayment date 2013 dividend
Barratt DevelopmentsPayment date 2014 dividend
  
Copyright 2014 Alliance News Limited. All Rights Reserved.
  

More News
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more
15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more
10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

Read more
10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

Read more
9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

Read more
9 Jan 2024 08:03

TOP NEWS: GSK to buy Aiolos Bio for up to USD1.4 billion

(Alliance News) - GSK PLC on Tuesday said it will acquire asthma drug developer Aiolos Bio Inc for USD1 billion upfront, as well as up to USD400 million in certain success-based milestone payments.

Read more
9 Jan 2024 07:16

GSK buys respiratory drug maker Aiolos for $1bn

(Sharecast News) - GSK said it was buying Aiolos, a clinical-stage biopharmaceutical company focused on treatment of respiratory and inflammatory conditions, for up to $1.4bn (£1.1bn).

Read more
8 Jan 2024 23:39

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 23:00

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
34567891011

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.